Obulytix

Obulytix

Foundation date

26/7/2023

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Proteins
• #Therapeutics - Anti-infectives

Therapeutic areas

• #Infectious and parasitic diseases

Obulytix is a biotechnology company focused on the discovery and development of a groundbreaking class of enzyme-based antibiotics to combat the most severe antibiotic-resistant bacteria. Our mission is to provide concrete solutions to the global antimicrobial resistance crisis and to save the lives of countless patients battling life-threatening conditions. The cornerstones of Obulytix’ groundbreaking approach are phage lysins, powerful enzymes derived from bacterial viruses known as bacteriophages.